| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $666.8M | +16.5% |
| Cost of Revenue | $240.7M | +7.5% |
| Gross Profit | $426.1M | +22.2% |
| R&D Expense | $66.7M | +14.5% |
| SG&A Expense | $152.8M | +4.7% |
| Operating Income | -$2.2M | +87.3% |
| Pre-tax Income | $1.9M | +108.8% |
| Income Tax | $54.6M | +736.7% |
| Net Income | -$52.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $296.1M | +334.3% |
| Accounts Receivable | $164.4M | +16.0% |
| Current Assets | $536.3M | +101.2% |
| Total Assets | $1.17B | +53.5% |
| Current Liabilities | $537.4M | +21.9% |
| Long-term Debt | $335.2M | +620.0% |
| Total Liabilities | $987.4M | +94.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $164.8M | +121.7% |
| Investing Cash Flow | -$158.2M | -139.0% |
| Financing Cash Flow | $231.3M | +973.3% |
| -302.7% |
| Stockholders' Equity |
| $179.4M |
| -29.1% |